semaglutide bmi Mind-blowing' weight loss with extends to adolescents with obesity VisualAbstract: Semaglutide and Cardiovascular Outcomes

Compounded, not brand Compounded semaglutide is not FDA-approved as a finished drug product and is not equivalent to Wegovy or Ozempic

Gene sets used were obtained from built-in Gene Ontology or curated databases v7.5 (Broad Institute) or described previously 78

FDA-Approved Uses in the USA In the United States, semaglutide is marketed under three main brand names, each approved for specific conditions: Wegovy: Specifically FDA-approved for chronic weight management in adults with obesity or overweight individuals with at least one weight-related condition (like high blood pressure)

FAQ Remember, seeking professional advice before starting any treatment is crucial